Journal
CELLULAR ONCOLOGY
Volume 42, Issue 4, Pages 555-569Publisher
SPRINGER
DOI: 10.1007/s13402-019-00445-z
Keywords
Triple negative breast cancer; Mitotic count; Artificial intelligence; Prognosis
Categories
Funding
- Radboud University Medical Center Institute for Health Sciences (RIHS)
Ask authors/readers for more resources
PurposeThe prognostic value of mitotic count for invasive breast cancer is firmly established. As yet, however, limited studies have been aimed at assessing mitotic counts as a prognostic factor for triple negative breast cancers (TNBC). Here, we assessed the prognostic value of absolute mitotic counts for TNBC, using both deep learning and manual procedures.MethodsA retrospective TNBC cohort (n=298) was used. The absolute manual mitotic count was assessed by averaging counts from three independent observers. Deep learning was performed using a convolutional neural network on digitized H&E slides. Multivariable Cox regression models for relapse-free survival and overall survival served as baseline models. These were expanded with dichotomized mitotic counts, attempting every possible cut-off value, and evaluated by means of the c-statistic.ResultsWe found that per 2mm(2) averaged manual mitotic counts ranged from 1 to 187 (mean 37.6, SD 23.4), whereas automatic counts ranged from 1 to 269 (mean 57.6; SD 42.2). None of the cut-off values improved the models' baseline c-statistic, for both manual and automatic assessments.ConclusionsBased on our results we conclude that the level of proliferation, as reflected by mitotic count, does not serve as a prognostic factor for TNBC. Therefore, TNBC patient management based on mitotic count should be discouraged.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available